Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Hepatitis B and C virus and hepatocellular carcinoma

"Antibody to hepatitis C virus (anti-HCV) was detected in 18.7% of patients with hepatocellular carcinoma ma (HCC)a nd in 10.9% of controls (P<0.001).The corresponding prevalences of hepatitis B surface antigen [HBsAg] were 59.3% and 50.0%(P<0.001). Using paticnts with non-hepatic disease as contro...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 1997
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/2216
042 |a dc 
720 |a Olubuyide, I. O.  |e author 
720 |a Aliyu, B.  |e author 
720 |a Olaleye, O. A.  |e author 
720 |a Ola, S. O.  |e author 
720 |a Olawuyi, F.  |e author 
720 |a Malabu, U. H.  |e author 
720 |a Odemuyiwa, S. O.  |e author 
720 |a Odaibo, G. N.  |e author 
720 |a Cook, G. C.  |e author 
260 |c 1997 
520 |a "Antibody to hepatitis C virus (anti-HCV) was detected in 18.7% of patients with hepatocellular carcinoma ma (HCC)a nd in 10.9% of controls (P<0.001).The corresponding prevalences of hepatitis B surface antigen [HBsAg] were 59.3% and 50.0%(P<0.001). Using paticnts with non-hepatic disease as controls stepwise logistics regression analysis indicated that both anti-HCV (odds ratio 6-88%; 9.5% confidence interval [CI] 1.63-9-77) and HBsAg (odds ratio 6.46; 95% Cl 1.68-18:13) were independent risk factors for HCC. Calculation of the incremental odds ratio indicated no interaction between hepatitis B virus {HBV) and HCV. Blood transfusion was a significant risk factor for acquiring HCV infection with odds ratios of 5.48 (95% CI 1.07-29.0) and 2.86 (95%. CI 1.31-22.72) for HCC cases and controls, respectively. The mean age HCC cases with HBsAg and anti-HCV was lower than that of HCC patients with anti-HCV alone (p<0.01). It is concluded that there is a high rate of HBV infection, and a low rate of HCV infection, among Nigerian patients with HCC. However, HBV and HCV are independent risk factors for the developement of HCC, with HBV having an effect more rapidly. Screening of blood products for transfusion might minimize the risk of HCV transmission." 
024 8 |a Transaction of the Royal Society of Tropical Medcine and Hygiene 91, pp. 38-41 
024 8 |a http://ir.library.ui.edu.ng/handle/123456789/2216 
245 0 0 |a Hepatitis B and C virus and hepatocellular carcinoma